Paragon Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Paragon Private Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$414K	Buy	826 +67	+9%	+$32.2K	0.11%	165
2026 Q1	$373K	Buy	759 +26	+4%	+$14.1K	0.12%	168
2025 Q4	$425K	Buy	733 +73	+11%	+$41.3K	0.13%	150
2025 Q3	$320K	Buy	660 +141	+27%	+$65.6K	0.1%	176
2025 Q2	$210K	Buy	519 +50	+11%	+$20.9K	0.08%	187
2025 Q1	$233K	Buy	469 +14	+3%	+$7.58K	0.11%	168
2024 Q4	$237K	Buy	455 +13	+3%	+$7.15K	0.11%	155
2024 Q3	$273K	Buy	+442	New	+$262K	0.14%	135
2024 Q2	–	Sell	-478	Closed	-$278K	–	162
2024 Q1	$278K	Sell	478 -2	-0.4%	-$1.12K	0.17%	120
2023 Q4	$255K	Buy	480 +20	+4%	+$9.68K	0.18%	118
2023 Q3	$233K	Sell	460 -10	-2%	-$5.33K	0.19%	112
2023 Q2	$245K	Sell	470 -16	-3%	-$8.63K	0.2%	112
2023 Q1	$280K	Sell	486 -4	-0.8%	-$2.25K	0.24%	102
2022 Q4	$270K	Sell	490 -9	-2%	-$4.77K	0.24%	103
2022 Q3	$257K	Sell	499 -104	-17%	-$58.2K	0.25%	98
2022 Q2	$328K	Hold	603	–	–	0.35%	75
2022 Q1	$333K	Hold	603	–	–	0.32%	76
2021 Q4	$402K	Buy	+603	New	+$376K	0.36%	74

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Paragon Private Wealth Management's TMO Position: Q2 2026 in Review

Paragon Private Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 8.8% in Q2 2026, buying an estimated $32.2K and bringing the position to 826 shares worth $414K. The position accounts for 0.11% of the portfolio, ranked #165.

Paragon Private Wealth Management first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $425K in Q4 2025. 1,147 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Paragon Private Wealth Management held 826 shares of Thermo Fisher Scientific worth $414K as of Q2 2026.
Paragon Private Wealth Management bought 67 Thermo Fisher Scientific shares in Q2 2026, an estimated $32.2K.
Thermo Fisher Scientific made up 0.11% of Paragon Private Wealth Management's portfolio in Q2 2026, its #165 holding.
Paragon Private Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
Paragon Private Wealth Management's Thermo Fisher Scientific position peaked at $425K in Q4 2025.
1,147 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Paragon Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.